Who
Steve Forte
EVP, Chief Financial Officer
Company insider
Files Form 4 as: EVP, Chief Financial Officer, Repare Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 1
- Sells
- 6
- Bought
- $100K
- Sold
- $27K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Jun 2020
- Last trade
- 28 Jan 2026
- Last filed
- 28 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jan 2026filed 28 Jan 2026 | Repare TherapeuticsBiotechnology | SEC FORM 4 Code D | —56,786 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —200,000 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —85,000 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code D | —200,000 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code D | —85,000 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code D | —500,000 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code D | —325,800 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —500,000 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —325,800 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeutics | SEC FORM 4 Code D | —56,786 | filing |
| 2 Apr 2025filed 4 Apr 2025 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 12 Mar 2025filed 14 Mar 2025 | Repare Therapeutics | SEC FORM 4 Sold | $7,8486,884 at $1.14 | filing |
| 4 Mar 2025filed 6 Mar 2025 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | Repare Therapeutics | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 1 Apr 2024filed 1 Apr 2024 | Repare Therapeutics | SEC FORM 4 Sold | $3,637789 at $4.61 | filing |
| 28 Mar 2024filed 1 Apr 2024 | Repare Therapeutics | SEC FORM 4 Sold | $3,812825 at $4.62 | filing |
| 27 Mar 2024filed 27 Mar 2024 | Repare Therapeutics | SEC FORM 4 Sold | $3,812825 at $4.62 | filing |
| 26 Mar 2024filed 27 Mar 2024 | Repare Therapeutics | SEC FORM 4 Sold | $3,795825 at $4.60 | filing |
| 25 Mar 2024filed 27 Mar 2024 | Repare Therapeutics | SEC FORM 4 Sold | $3,952825 at $4.79 | filing |
News
No headline names them, or the companies they trade most, lately.